Insulet Corporation (FRA:GOV)

Market Cap	18.41B
Revenue (ttm)	2.15B
Net Income (ttm)	209.84M
Shares Out	n/a
EPS (ttm)	2.94
PE Ratio	87.75
Forward PE	52.33
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	6
Open	269.50
Previous Close	271.00
Day's Range	269.50 - 269.50
52-Week Range	205.10 - 304.00
Beta	n/a
RSI	45.80
Earnings Date	Feb 26, 2026

About Insulet

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is cont...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2000
• Employees: 3,900
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: GOV

Financial Performance

In 2024, Insulet's revenue was $2.07 billion, an increase of 22.07% compared to the previous year's $1.70 billion. Earnings were $418.30 million, an increase of 102.76%.

Financial numbers in USD